Terms: = Breast cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Treatment
9 results:
1. Distinct profiles of proliferating CD8+/tcf1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes.
Ntostoglou K; Theodorou SDP; Proctor T; Nikas IP; Awounvo S; Sepsa A; Georgoulias V; Ryu HS; Pateras IS; Kittas C
Cancer Immunol Immunother; 2024 Feb; 73(3):46. PubMed ID: 38349444
[TBL] [Abstract] [Full Text] [Related]
2. Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8
Yu A; Hu J; Fu L; Huang G; Deng D; Zhang M; Wang Y; Shu G; Jing L; Li H; Chen X; Yang T; Wei J; Chen Z; Zu X; Luo J
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37802603
[TBL] [Abstract] [Full Text] [Related]
3. Eribulin promotes proliferation of CD8
Shimizu T; Oba T; Oshi M; Ito KI
Breast Cancer Res Treat; 2024 Jan; 203(1):57-71. PubMed ID: 37733186
[TBL] [Abstract] [Full Text] [Related]
4. Spatial predictors of immunotherapy response in triple-negative breast cancer.
Wang XQ; Danenberg E; Huang CS; Egle D; Callari M; Bermejo B; Dugo M; Zamagni C; Thill M; Anton A; Zambelli S; Russo S; Ciruelos EM; Greil R; Győrffy B; Semiglazov V; Colleoni M; Kelly CM; Mariani G; Del Mastro L; Biasi O; Seitz RS; Valagussa P; Viale G; Gianni L; Bianchini G; Ali HR
Nature; 2023 Sep; 621(7980):868-876. PubMed ID: 37674077
[TBL] [Abstract] [Full Text] [Related]
5. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis.
Hassing CMS; Nielsen DL; Knoop AS; Tvedskov THF; Kroman N; Lænkholm AV; Juhl CB; Kümler I
Crit Rev Oncol Hematol; 2023 Apr; 184():103952. PubMed ID: 36854373
[TBL] [Abstract] [Full Text] [Related]
7. Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network.
Hequet D; Hamy AS; Girard N; Laas E; Coussy F; Rouzier R; Preau M; Delrieu L; Dumas A; Reyal F
Support Care Cancer; 2022 Jul; 30(7):5991-5999. PubMed ID: 35396963
[TBL] [Abstract] [Full Text] [Related]
8. Blocking Short-Form Ron Eliminates breast cancer Metastases through Accumulation of Stem-Like CD4+ T Cells That Subvert Immunosuppression.
Lai SA; Gundlapalli H; Ekiz HA; Jiang A; Fernandez E; Welm AL
Cancer Discov; 2021 Dec; 11(12):3178-3197. PubMed ID: 34330779
[TBL] [Abstract] [Full Text] [Related]
9. Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by tcf1/[beta]-catenin.
Bataille F; Rogler G; Modes K; Poser I; Schuierer M; Dietmaier W; Ruemmele P; Mühlbauer M; Wallner S; Hellerbrand C; Bosserhoff AK
Lab Invest; 2005 Jan; 85(1):124-36. PubMed ID: 15492751
[TBL] [Abstract] [Full Text] [Related]
